Article
Treatment of hepatitis C: a systematic review.
JAMA - 13 Aug 2014
Kohli Anita, Shaffer Ashton, Sherman Amy, Kottilil Shyam
Abstract excerpt
IMPORTANCE: Hepatitis C virus (HCV) infects more than 185 million individuals worldwide. Twenty percent of patients chronically infected with HCV progress to cirrhosis. New, simpler therapeutics using direct-acting antivirals that target various stages of the HCV life cycle are in development to eradicate HCV without concomitant interferon. OBJECTIVES: To summarize published evidence on safety, efficacy (measured...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
